Convenient and accesible cancer screening blood test that can be conducted at routine medical check-ups. Providing an easy way to all levels of society to detect cancer early, when it can be cured.

Biowissenschaften & Gesundheitspflege

Seed Stage




Canostix is developing a blood-based cancer test that combines photonics and machine learning, potentially beating liquid biopsy in regard to accuracy, cost and convenience. Starting with the five most common cancers, we create a constantly evolving software solution that upgrades commercially available hardware into top-of-the-line screening machines.


Established research cooperation in India - enabling much faster and more cost efficient development

Completed Proof-of-Concept with great results

Multidisciplinary team with decades of research and enterpreneurial experience

First company implementing population-scale clinical studies in the area of spectroscopic diagnostics

Canostix Team Members

  • Validierte Teammitglieder auf der Startbase
  • Eingetragen in einem deutschen Handelsregister
  • Hauptquartier in Deutschland
  • Skalierbares Geschäftsmodell
  • Innovatives Geschäftsmodell


Leben retten durch Revolutionierung der Krebsvorsorge
  • 2018
  • 1-10 Mitarbeiter
  • Canostix GmbH (limited)
  • Handelsregister
  • Berlin, DE